121 related articles for article (PubMed ID: 19681655)
1. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.
Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Krsek M; Haluzík M
Physiol Res; 2010; 59(3):415-422. PubMed ID: 19681655
[TBL] [Abstract][Full Text] [Related]
2. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.
Dostálová I; Kaválková P; Haluzíková D; Lacinová Z; Mráz M; Papezová H; Haluzík M
J Clin Endocrinol Metab; 2008 Sep; 93(9):3627-32. PubMed ID: 18559909
[TBL] [Abstract][Full Text] [Related]
4. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS
Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome.
Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Kršek M; Haluzík M
Physiol Res; 2010; 59(6):963-971. PubMed ID: 20533865
[TBL] [Abstract][Full Text] [Related]
8. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity.
Grottoli S; Gauna C; Tassone F; Aimaretti G; Corneli G; Wu Z; Strasburger CJ; Dieguez C; Casanueva FF; Ghigo E; Maccario M
Clin Endocrinol (Oxf); 2003 Feb; 58(2):220-8. PubMed ID: 12580939
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
10. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
[TBL] [Abstract][Full Text] [Related]
11. Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21.
Marchelek-Myśliwiec M; Dziedziejko V; Nowosiad-Magda M; Dołęgowska K; Dołęgowska B; Pawlik A; Safranow K; Wiśniewska M; Stępniewska J; Domański M; Ciechanowski K
Kidney Blood Press Res; 2019; 44(5):1207-1218. PubMed ID: 31614355
[TBL] [Abstract][Full Text] [Related]
12. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.
Maccario M; Tassone F; Gauna C; Oleandri SE; Aimaretti G; Procopio M; Grottoli S; Pflaum CD; Strasburger CJ; Ghigo E
Eur J Endocrinol; 2001 Mar; 144(3):251-6. PubMed ID: 11248744
[TBL] [Abstract][Full Text] [Related]
14. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women.
Xu Y; Ma X; Pan X; He X; Xiao Y; Bao Y
Cardiovasc Diabetol; 2018 Nov; 17(1):143. PubMed ID: 30424752
[TBL] [Abstract][Full Text] [Related]
15. Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status.
Hu X; Xiong Q; Xu Y; Zhang X; Pan X; Ma X; Bao Y; Jia W
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):119-125. PubMed ID: 29174027
[TBL] [Abstract][Full Text] [Related]
16. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations.
Sánchez-Infantes D; Gallego-Escuredo JM; Díaz M; Aragonés G; Sebastiani G; López-Bermejo A; de Zegher F; Domingo P; Villarroya F; Ibáñez L
Int J Obes (Lond); 2015 May; 39(5):742-6. PubMed ID: 25599612
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.
Fallo F; Scarda A; Sonino N; Paoletta A; Boscaro M; Pagano C; Federspil G; Vettor R
Eur J Endocrinol; 2004 Mar; 150(3):339-44. PubMed ID: 15012619
[TBL] [Abstract][Full Text] [Related]
18. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
[TBL] [Abstract][Full Text] [Related]
19. Hormonal and metabolic rhythms in Cushing's syndrome.
Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF
Metabolism; 1980 Oct; 29(11):1046-52. PubMed ID: 7001175
[TBL] [Abstract][Full Text] [Related]
20. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
